Leukemic cells from both groups of mice expressed variable levels of CD4, CD8, CD24, and CD25 cell surface markers, characteristic of bona fide TEL-JAK2 T-cell leukemia (data not shown). This evidence concerns the gene JAK2 and T-cell leukemia.